Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
230,268,780
-
Share change
-
-18,402,742
-
Total reported value
-
$9,590,935,017
-
Put/Call ratio
-
99%
-
Price per share
-
$41.65
-
Number of holders
-
706
-
Value change
-
-$824,396,346
-
Number of buys
-
326
-
Number of sells
-
288
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2015
As of 30 Jun 2015,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
706 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
230,268,780 shares.
The largest 10 holders included
Dodge & Cox, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, FMR LLC, STATE STREET CORP, JPMORGAN CHASE & CO, FEDERATED INVESTORS INC /PA/, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
707
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.